Achaogen, Inc. (AKAO)
(Delayed Data from NSDQ)
$0.11 USD
0.00 (0.00%)
Updated Apr 25, 2019 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[AKAO]
Reports for Purchase
Showing records 1 - 20 ( 119 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Dropping Coverage Due to Realignment of Analyst Resources
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Conserving Cash for Ongoing Strategic Review as Focused ZEMDRI Launch Continues
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Industry: Medical - Drugs
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Drugs
Industry: Medical - Drugs
As Strategic Review Continues, Positive ZEMDRI Updates Lead to Equity Raise and Expanded Runway; Adjust PT to $2
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Seeking Strategic Options Before Cash Runs out; Downgrade to Neutral and cut PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Drugs
Downgrading to NEUTRAL and Lowering PT to $3; Exploring Strategic Alternatives
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Industry: Medical - Drugs
Better Late than Never: AKAO Seeks Strategic Alternatives - Buy
Provider: G.RESEARCH, LLC
Analyst: KEDRA K
Industry: Medical - Drugs
ValuEngine Detailed Valuation Report for AKAO
Provider: ValuEngine, Inc
Industry: Medical - Drugs
Industry: Medical - Drugs
ESCMID/ASM 2018: Updates on SPR994, SPR206, and ZEMDRI
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.